Regeneron Pharmaceuticals' Inventory Average rose 573.11% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.2 billion, marking a year-over-year increase of 573.11%. This contributed to the annual value of $3.1 billion for FY2025, which is 1094.43% up from last year.
Latest data reveals that Regeneron Pharmaceuticals reported Inventory Average of $3.2 billion as of Q4 2025, which was up 573.11% from $3.2 billion recorded in Q3 2025.
Over the past 5 years, Regeneron Pharmaceuticals' Inventory Average peaked at $3.2 billion during Q3 2025, and registered a low of $2.0 billion during Q1 2022.
In the last 5 years, Regeneron Pharmaceuticals' Inventory Average had a median value of $2.5 billion in 2023 and averaged $2.6 billion.
As far as peak fluctuations go, Regeneron Pharmaceuticals' Inventory Average surged by 4090.94% in 2021, and later tumbled by 339.35% in 2022.
Regeneron Pharmaceuticals' Inventory Average (Quarter) stood at $2.0 billion in 2021, then grew by 20.2% to $2.4 billion in 2022, then grew by 6.82% to $2.6 billion in 2023, then increased by 18.72% to $3.1 billion in 2024, then grew by 5.73% to $3.2 billion in 2025.
Its Inventory Average was $3.2 billion in Q4 2025, compared to $3.2 billion in Q3 2025 and $3.2 billion in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value